These cereblon-based compounds degraded FAK with a DC50 of about 30 nM on a panel of eleven HCC cell lines, but, unfortunately, despite their good action on FAK depletion, both were not able to block proliferation of the selected cancer cell lines. The gene discussed is PTK2; the disease is cancer.